Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

49.53 +0.63 (+1.29%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,342,411
Open 49.71
Bid (Size) 49.00 (800)
Ask (Size) 49.64 (300)
Prev. Close 48.90
Today's Range 49.20 - 49.73
52wk Range 44.62 - 60.12
Shares Outstanding 1,250,690,553
Dividend Yield 4.47%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Is Alnylam Pharmaceuticals a Millionaire Maker? ↗
This hot biotech stock could have a lot more room to run. 
Via The Motley Fool
News headline image
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths ↗
Moderna tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children. 
Via Investor's Business Daily
Topics Death

Performance

YTD
+2.8%
+2.8%
1 Month
+0.1%
+0.1%
3 Month
+5.8%
+5.8%
6 Month
-0.4%
-0.4%
1 Year
+2.2%
+2.2%

More News

Read More
News headline image
Should You Buy This Biotech Stock That Just Gained 5% in 1 Day? ↗
Via The Motley Fool
News headline image
Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation ↗
Via Investor's Business Daily
Topics Fraud
News headline image
Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines
Via TokenRing AI
Topics Artificial Intelligence Economy Product Recall
News headline image
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Why Roche Holding Stock Popped Today ↗
Via The Motley Fool
News headline image
TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results ↗
Via Investor's Business Daily
News headline image
Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60% ↗
Via Investor's Business Daily
News headline image
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
News headline image
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
Via TokenRing AI
Topics Artificial Intelligence
News headline image
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
News headline image
Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness ↗
Via Benzinga
News headline image
UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey
From Medidata Solutions, Inc.
Via GlobeNewswire
News headline image
Sanofi Soars as Dupixent Sales Near €5 Billion Amidst Intensifying Trump Drug Pricing Negotiations
Via MarketMinute
Topics Government World Trade
News headline image
Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark ↗
Via Benzinga
Topics Earnings
News headline image
Sanofi Jumps As Third-Quarter Dupixent Sales Near $5 Billion ↗
Via Investor's Business Daily
News headline image
Earnings Scheduled For October 24, 2025 ↗
Via Benzinga
News headline image
Oil Stocks Rally On Trump's Russia Sanctions: What's Moving Markets Thursday? ↗
Via Benzinga
Topics Government
News headline image
Examining the Future: Sanofi's Earnings Outlook ↗
Via Benzinga
News headline image
Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey
From Medidata Solutions, Inc.
Via GlobeNewswire
News headline image
Sanofi Drug Shows Superior Efficacy In Genetic Disease Compared To Current Standard Therapy ↗
Via Benzinga
News headline image
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
Via MarketMinute
News headline image
Sanofi's Rezurock Approval Stumbles In EU For Chronic Graft-Vs-Host Disease ↗
Via Benzinga

Frequently Asked Questions

Is Sanofi - American Depositary Shares publicly traded?
Yes, Sanofi - American Depositary Shares is publicly traded.
What exchange does Sanofi - American Depositary Shares trade on?
Sanofi - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Sanofi - American Depositary Shares?
The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market
What is the current price of Sanofi - American Depositary Shares?
The current price of Sanofi - American Depositary Shares is 49.53
When was Sanofi - American Depositary Shares last traded?
The last trade of Sanofi - American Depositary Shares was at 12/05/25 04:00 PM ET
What is the market capitalization of Sanofi - American Depositary Shares?
The market capitalization of Sanofi - American Depositary Shares is 61.95B
How many shares of Sanofi - American Depositary Shares are outstanding?
Sanofi - American Depositary Shares has 62B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.